Keenova Therapeutics plc Retained Earnings
Keenova Therapeutics plc had Retained Earnings of -$385.70 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-11
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$385.70M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$165.20M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$51.70M.
- 2025-09-26: Retained Earnings (Accumulated Deficit) $121.40M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$385.70M 10-Q · filed 2026-08-11 |
| 2026-03-31 | -$165.20M 10-Q · filed 2026-05-12 |
| 2025-12-31 | -$51.70M 10-Q · filed 2026-08-11 |
| 2025-09-26 | $121.40M 10-Q · filed 2025-11-10 |
| 2025-06-27 | $415.30M 10-Q · filed 2025-08-06 |
| 2025-03-28 | $412.90M 10-Q · filed 2025-05-12 |
| 2024-12-27 | $439.70M 10-K · filed 2026-04-15 |
| 2024-09-27 | -$173.10M 10-Q · filed 2024-11-05 |
| 2024-06-28 | -$146.90M 10-Q · filed 2024-08-06 |
| 2024-03-29 | -$103.60M 10-Q · filed 2024-05-09 |
| 2023-12-29 | -$38.20M 10-K · filed 2025-03-13 |
| 2023-09-29 | -$3.31B 10-Q · filed 2023-11-07 |
| 2023-06-30 | -$1.59B 10-Q · filed 2023-08-09 |
| 2023-03-31 | -$837.50M 10-Q · filed 2023-05-09 |
| 2022-12-30 | -$588.20M 10-K · filed 2024-03-26 |
| 2022-09-30 | -$348.60M 10-Q · filed 2022-11-08 |
| 2022-07-01 | -$63.70M 10-Q · filed 2022-08-11 |
| 2022-04-01 | -$3.80B 10-Q · filed 2022-05-03 |
| 2021-12-31 | -$3.68B 10-K · filed 2023-03-03 |
| 2021-09-24 | -$3.47B 10-Q · filed 2021-11-02 |
| 2021-06-25 | -$3.21B 10-Q · filed 2021-08-03 |
| 2021-03-26 | -$3.11B 10-Q · filed 2021-05-04 |
| 2020-12-25 | -$2.96B 10-K · filed 2022-03-15 |
| 2020-09-25 | -$2.81B 10-Q · filed 2020-11-03 |
| 2020-06-26 | -$3.00B 10-Q · filed 2020-08-04 |
| 2020-03-27 | -$2.07B 10-Q · filed 2020-05-06 |
| 2019-12-27 | -$2.02B 10-K · filed 2021-03-10 |
| 2019-09-27 | -$859.80M 10-Q · filed 2019-11-05 |
| 2019-06-28 | -$857.50M 10-Q · filed 2019-08-06 |
| 2019-03-29 | -$863.70M 10-Q · filed 2019-05-07 |
| 2018-12-28 | -$1.02B 10-K · filed 2020-02-26 |
| 2018-09-28 | $2.70B 10-Q · filed 2018-11-06 |
| 2018-06-29 | $2.59B 10-Q · filed 2018-08-07 |
| 2018-03-30 | $2.57B 10-Q · filed 2018-05-08 |
| 2017-12-29 | $2.59B 10-K · filed 2019-02-26 |
| 2017-09-29 | $980.60M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $917.50M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $855.60M 10-Q · filed 2017-05-08 |
| 2016-12-30 | $529.00M 10-K · filed 2018-02-27 |
| 2016-09-30 | $682.60M 10-QT · filed 2017-02-07 |
| 2016-06-24 | $567.60M 10-Q · filed 2016-08-02 |
| 2016-03-25 | $368.30M 10-Q · filed 2016-05-03 |
| 2015-12-25 | $250.00M 10-Q · filed 2016-02-02 |
| 2015-09-25 | $38.90M 10-K · filed 2016-11-29 |
| 2015-06-26 | -$36.30M 10-Q · filed 2015-08-04 |
| 2015-03-27 | -$94.30M 10-Q · filed 2015-05-05 |
| 2014-12-26 | -$193.10M 10-Q · filed 2015-02-03 |
| 2014-09-26 | -$285.80M 10-K · filed 2015-11-24 |
| 2014-06-27 | $66.60M 10-Q · filed 2014-08-07 |
| 2014-03-28 | $90.70M 10-Q · filed 2014-05-08 |
| 2013-12-27 | $79.10M 10-Q · filed 2014-02-07 |
| 2013-09-27 | $33.50M 8-K · filed 2015-04-03 |
| 2012-09-28 | $0.00 10-K · filed 2013-12-13 |